|
|
Volumn 5 Suppl 1, Issue , 2006, Pages
|
|
Tyrosine kinase inhibitors compared with cytokine therapy for metastatic renal cell carcinoma: overview of recent clinical trials differentiating clinical response and adverse effects.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
CYTOKINE;
INDOLE DERIVATIVE;
INTERFERON;
INTERLEUKIN 2;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
SORAFENIB;
SUNITINIB;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
CYTOKINES;
HUMANS;
INDOLES;
INTERFERONS;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PYRIDINES;
PYRROLES;
MLCS;
MLOWN;
|
|
EID: 34047215913
PISSN: 15587673
EISSN: None
Source Type: Journal
DOI: 10.3816/CGC.2006.s.003 Document Type: Article |
|
Times cited : (5)
|
|
References (24)
|
